In this update, we reveal the latest data and patient experiences with Project Twenty21, and reveal some exciting news from NICE. We also announce new events related to the project and how you can get involved. Learn more about Project Twenty21 Last month we asked for your stories, and we’re thrilled with the response we …
We are greatly encouraged by the news that NICE updated their guidelines around medical cannabis for children with severe epilepsy. The clinical guidance now clearly states: ‘There is no recommendation against the use of cannabis-based medicinal products’ – meaning that Matt and Ali Hughes were able to drop their court case over the prescribing guidelines …
Last month we asked for your stories, and we’re thrilled with the response we received. These provide us with valuable insights and snapshots into the experiences of our patients, both the benefits and the challenges. Thank you so much for submitting these, and we would love to gather more of these stories in the coming …
In this update, we reveal the latest data from Project Twenty21 and unveil a new online form that patients can use to share their story and experience with medical cannabis through Project Twenty21. We also answer some of the most frequent questions that are asked about medical cannabis through Project Twenty21, and clarify the step-by-step …
A Closer Look at the Families Struggling to Cope with the Huge Financial and Personal Burden of Accessing Medical Cannabis to Treat Childhood Epilepsy By Danielle Johnson, Clinical Scientist in Neurophysiology and member of the Medical Cannabis Working Group at Drug Science In recent years, the case for medical cannabis as a treatment for drug-resistant …
Download our letter to the Advisory Council on the Misuse of Drugs Dear Owen Bowden-Jones I am writing on behalf of Drug Science in relation to the ACMD update report on medical cannabis last November. The Drug Science Medical Cannabis Working Group (MCWG) has now had time to discuss your report and I wanted …